CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CroíValve is developing a non-invasive device for treating tricuspid valve disease, a condition affecting many patients. This innovative solution aims to improve patient outcomes by providing a safer alternative to traditional open-heart surgery.
CroíValve is an innovative SME with the mission to lead the treatment of tricuspid valve disease and transform the lives of patients who currently face certain death.
In the US and EU, 550,000 patients present with tricuspid valve disease annually.
Current treatment involves highly invasive, risky open-heart surgery and <1% receive this due to the risks involved.
Recent clinical data is highlighting that the ""forgotten tricuspid valve"" must be treated.
CroíValve has developed a non-invasive de…
CROIVALVE LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
